NCT02344134View on ClinicalTrials.gov

Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

1,155

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

May 31, 2014

Conditions
Influenza, Human
Interventions
BIOLOGICAL

NBP607

0.5 mL, intramuscular, a single dose

BIOLOGICAL

Agrippal S1

0.5 mL, intramuscular, a single dose

All Listed Sponsors
lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT02344134 - Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly Subjects | Biotech Hunter | Biotech Hunter